Work

Long-term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for up to 128 Weeks: Insights From Valor-hcm Trial

Year: 2025

Type: article

Source: Journal of the American College of Cardiology

DOI: 10.1016/s0735-1097(25)01910-2

Authors: Milind Y. Desai, Yuichiro Okushi, Jeffrey Benjamin Geske, Anjali Tiku Owens, Qiuqing Wang, Sara Saberi, Andrew Wang, Paul Cremer, Neal K. Lakdawala, Mark V. Sherrid, Albree Tower-Rader, David R. Fermin, Mark A. Zenker, Srihari S. Naidu, Kathy Lampl, Amy Sehnert, Steven E. Nissen, Zoran Popovic

Language: English

Topic: Cardiomyopathy and Myosin Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $7,166

OpenAlex ID: W4408962371

FWCI: 0.633

Cites:

Cited by: 1

Related to: 10